Literature DB >> 17920692

Predicting recovery from episodes of major depression.

David A Solomon1, Andrew C Leon, William Coryell, Timothy I Mueller, Michael Posternak, Jean Endicott, Martin B Keller.   

Abstract

BACKGROUND: This study examined psychosocial functioning as a predictor of recovery from episodes of unipolar major depression.
METHODS: 231 subjects diagnosed with major depressive disorder according to Research Diagnostic Criteria were prospectively followed for up to 20 years as part of the NIMH Collaborative Depression Study. The association between psychosocial functioning and recovery from episodes of unipolar major depression was analyzed with a mixed-effects logistic regression model which controlled for cumulative morbidity, defined as the amount of time ill with major depression during prospective follow-up. Recovery was defined as at least eight consecutive weeks with either no symptoms of major depression, or only one or two symptoms at a mild level of severity.
RESULTS: In the mixed-effects model, a one standard deviation increase in psychosocial impairment was significantly associated with a 22% decrease in the likelihood of subsequent recovery from an episode of major depression (OR=0.78, 95% CI: 0.74-0.82, Z=-3.17, p<0.002). Also, a one standard deviation increase in cumulative morbidity was significantly associated with a 61% decrease in the probability of recovery (OR=0.3899, 95% CI: 0.3894-0.3903, Z=-7.21, p<0.001). LIMITATIONS: The generalizability of the study is limited in so far as subjects were recruited as they sought treatment at academic medical centers. The analyses examined the relationship between psychosocial functioning and recovery from major depression, and did not include episodes of minor depression. Furthermore, this was an observational study and the investigators did not control treatment.
CONCLUSIONS: Assessment of psychosocial impairment may help identify patients less likely to recover from an episode of major depression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920692      PMCID: PMC2405955          DOI: 10.1016/j.jad.2007.09.001

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  10 in total

1.  MIXOR: a computer program for mixed-effects ordinal regression analysis.

Authors:  D Hedeker; R D Gibbons
Journal:  Comput Methods Programs Biomed       Date:  1996-03       Impact factor: 5.428

2.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

3.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment.

Authors:  A C Leon; D A Solomon; T I Mueller; C L Turvey; J Endicott; M B Keller
Journal:  Psychol Med       Date:  1999-07       Impact factor: 7.723

5.  Hamilton Depression Rating Scale. Extracted from Regular and Change Versions of the Schedule for Affective Disorders and Schizophrenia.

Authors:  J Endicott; J Cohen; J Nee; J Fleiss; S Sarantakos
Journal:  Arch Gen Psychiatry       Date:  1981-01

6.  Research diagnostic criteria: rationale and reliability.

Authors:  R L Spitzer; J Endicott; E Robins
Journal:  Arch Gen Psychiatry       Date:  1978-06

7.  Recovery from major depression. A 10-year prospective follow-up across multiple episodes.

Authors:  D A Solomon; M B Keller; A C Leon; T I Mueller; M T Shea; M Warshaw; J D Maser; W Coryell; J Endicott
Journal:  Arch Gen Psychiatry       Date:  1997-11

8.  A diagnostic interview: the schedule for affective disorders and schizophrenia.

Authors:  J Endicott; R L Spitzer
Journal:  Arch Gen Psychiatry       Date:  1978-07

9.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

10.  The Longitudinal Interval Follow-up Evaluation. A comprehensive method for assessing outcome in prospective longitudinal studies.

Authors:  M B Keller; P W Lavori; B Friedman; E Nielsen; J Endicott; P McDonald-Scott; N C Andreasen
Journal:  Arch Gen Psychiatry       Date:  1987-06
  10 in total
  12 in total

Review 1.  Defining and measuring functional recovery from depression.

Authors:  Tracy L Greer; Benji T Kurian; Madhukar H Trivedi
Journal:  CNS Drugs       Date:  2010-04       Impact factor: 5.749

2.  Weight concerns, mood, and postpartum smoking relapse.

Authors:  Michele D Levine; Marsha D Marcus; Melissa A Kalarchian; Patricia R Houck; Yu Cheng
Journal:  Am J Prev Med       Date:  2010-10       Impact factor: 5.043

3.  Beyond symptomatic improvement:assessing real-world outcomes in patients with major depressive disorder.

Authors:  Alan M Langlieb; Christine J Guico-Pabia
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

4.  The course of major depressive disorder from childhood to young adulthood: Recovery and recurrence in a longitudinal observational study.

Authors:  Maria Kovacs; Scott Obrosky; Charles George
Journal:  J Affect Disord       Date:  2016-05-24       Impact factor: 4.839

5.  Development and Validation of the Health of the Nation Outcome Scales-Residential Facility (HoNOS-RF).

Authors:  Laura Pedrini; Mariangela Lanfredi; Clarissa Ferrari; Sonia Andreose; Pasquale Basso; Rossella Beneduce; Rosaria Pioli; Luciana Rillosi; Giuseppe Rossi; Roberta Rossi; Giovanni Battista Tura
Journal:  Psychiatr Q       Date:  2018-06

6.  Levomilnacipran ER 40 mg and 80 mg in patients with major depressive disorder: a phase III, randomized, double-blind, fixed-dose, placebo-controlled study.

Authors:  David Bakish; Anjana Bose; Carl Gommoll; Changzheng Chen; Rene Nunez; William M Greenberg; Michael Liebowitz; Arif Khan
Journal:  J Psychiatry Neurosci       Date:  2014-01       Impact factor: 6.186

7.  Continuation-phase cognitive therapy's effects on remission and recovery from depression.

Authors:  Jeffrey R Vittengl; Lee Anna Clark; Robin B Jarrett
Journal:  J Consult Clin Psychol       Date:  2009-04

8.  The role of attention to emotion in recovery from major depressive disorder.

Authors:  Renee J Thompson; Jutta Mata; Susanne M Jaeggi; Martin Buschkuehl; John Jonides; Ian H Gotlib
Journal:  Depress Res Treat       Date:  2013-06-18

9.  Using Logistic Regression to Predict Onset and Recovery With Tau Equivalency.

Authors:  Kimmo Sorjonen; Michael Lundberg; Bo Melin
Journal:  Front Psychol       Date:  2018-10-01

10.  Cognitive conflicts in major depression: between desired change and personal coherence.

Authors:  Guillem Feixas; Adrián Montesano; Victoria Compañ; Marta Salla; Gloria Dada; Olga Pucurull; Adriana Trujillo; Clara Paz; Dámaris Muñoz; Miquel Gasol; Luis Ángel Saúl; Fernando Lana; Ignasi Bros; Eugenia Ribeiro; David Winter; María Jesús Carrera-Fernández; Joan Guàrdia
Journal:  Br J Clin Psychol       Date:  2014-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.